Suppr超能文献

揭示消炎利胆片(XYLDT)治疗胆汁淤积性肝损伤的药理机制及主要药效草药。

Uncovering the pharmacological mechanism and the main herbal medicine contributing to the efficacy of Xiaoyanlidan Tablet (XYLDT) in treating cholestatic liver injury.

作者信息

Wu Zeqi, Shi Jionghua, Zhang Yue, Shi Ruijia, Guo Qian, Zhang Jingnan, Lu Bin, Huang Zhenlin, Ji Lili

机构信息

The MOE Key Laboratory for Standardization of Chinese Medicines, Shanghai Key Laboratory of Compound Chinese Medicines and the SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.

School of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.

出版信息

J Ethnopharmacol. 2025 Jan 31;340:119163. doi: 10.1016/j.jep.2024.119163. Epub 2024 Nov 28.

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE

Xiaoyanlidan Tablet (XYLDT) is a Chinese patent medicine consisted of three traditional Chinese medicines (TCMs) including Andrographis Herba (AH), Linearstripe Rabdosia Herba (LRH) and Picrasmae Ramulus et Folium (PRF). In Chinese traditional medicine theory, XYLDT has the "heat-clearing, dampness-dispelling and gallbladder function promoting" properties, and was widely used in the clinic for decades to treat pain in the subcostal region or bitter taste in the mouth, which were induced by liver-gallbladder dampness-heat. Meanwhile, it was also used for the therapy of acute cholecystitis and cholangitis.

AIM OF THE STUDY

To explore the mechanism of XYLDT in alleviating the alpha-naphthylisothiocyanate (ANIT)-induced cholestatic liver injury (CLI), and to find out which TCM consisted in XYLDT contributed the most to the therapeutic efficacy of XYLDT.

METHODS

ANIT was orally given to mice to induce CLI in vivo. Each TCM in XYLDT alone, XYLDT-without one TCM or XYLDT was orally given to mice before or after ANIT administration. Serum biochemical indicators were measured by using commercial kits. Liver histopathology was observed. Clinical data analysis was used to predict molecules and signal pathways involved in the XYLDT-provided improvement on CLI, which was further verified by using RT-PCR and Western-blot assay.

RESULTS

The alleviation of XYLDT on ANIT-induced CLI was proved by the data of serum biochemical indicators and liver histological observation. Results from clinical data analysis indicated that XYLDT improved CLI via improving mitochondrial function, oxidative phosphorylation, oxidative stress. XYLDT reduced the ROS level, MDA content, and increased GSH content. Meanwhile XYLDT improved the level of Nrf2 into the nucleus and mRNA expression of Nqo1, Gclc, Gclm. Andrographis Herba was proved to be the most crucial for the XYLDT-provided therapeutic efficacy on CLI. Moreover, andrographolide and neoandrographolide, two main active compounds in Andrographis Herba, had the apparent anti-inflammatory ability in LPS-stimulated RAW264.7 cells. Andrographolide also promoted nuclear translocation activation of Nrf2 in antioxidant response elements (ARE)-luciferin transfected L-02 cells.

CONCLUSION

XYLDT alleviated the ANIT-induced CLI via improving oxidative stress and activated Nrf2-related signaling pathways. Andrographis Herba was important for the XYLDT-provided alleviation on CLI.

摘要

民族药理学相关性

消炎利胆片(XYLDT)是一种由穿心莲(AH)、溪黄草(LRH)和黄柏(PRF)三味中药组成的中成药。在中医理论中,消炎利胆片具有“清热、祛湿、利胆”的功效,数十年来在临床上广泛用于治疗由肝胆湿热引起的胁肋疼痛或口苦,同时也用于治疗急性胆囊炎和胆管炎。

研究目的

探讨消炎利胆片减轻α-萘异硫氰酸酯(ANIT)诱导的胆汁淤积性肝损伤(CLI)的机制,并找出消炎利胆片中哪种中药对其治疗效果贡献最大。

方法

给小鼠口服ANIT以在体内诱导CLI。在给予ANIT之前或之后,将消炎利胆片中的每种中药单独、不含一种中药的消炎利胆片或消炎利胆片口服给予小鼠。使用商业试剂盒测量血清生化指标。观察肝脏组织病理学。通过临床数据分析预测消炎利胆片改善CLI所涉及的分子和信号通路,并通过RT-PCR和蛋白质免疫印迹法进行进一步验证。

结果

血清生化指标和肝脏组织学观察数据证明了消炎利胆片对ANIT诱导的CLI有缓解作用。临床数据分析结果表明,消炎利胆片通过改善线粒体功能、氧化磷酸化、氧化应激来改善CLI。消炎利胆片降低了活性氧水平、丙二醛含量,并增加了谷胱甘肽含量。同时,消炎利胆片提高了Nrf2进入细胞核的水平以及Nqo1、Gclc、Gclm的mRNA表达。穿心莲被证明对消炎利胆片对CLI的治疗效果最为关键。此外,穿心莲中的两种主要活性成分穿心莲内酯和新穿心莲内酯在脂多糖刺激的RAW264.7细胞中具有明显的抗炎能力。穿心莲内酯还促进了抗氧化反应元件(ARE)-荧光素酶转染的L-02细胞中Nrf2的核转位激活。

结论

消炎利胆片通过改善氧化应激和激活Nrf2相关信号通路减轻ANIT诱导的CLI。穿心莲对消炎利胆片减轻CLI具有重要作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验